YD Bio Limited Ordinary Shares
YDES · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,412 | $14 | $3,788 | $8,704 |
| Dep. & Amort. | $105 | $2 | $0 | $0 |
| Deferred Tax | $27 | $4 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$568 | -$127 | -$697 | $632 |
| Other Non-Cash | $11 | $51 | -$6,113 | -$10,025 |
| Operating Cash Flow | -$1,837 | -$56 | -$3,023 | -$688 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$75 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$529 | -$1,401 | -$1,150 |
| Inv. Sales/Matur. | $10 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,836 | $529 | $101,777 | $0 |
| Investing Cash Flow | -$2,901 | -$0 | $100,376 | -$1,150 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$33 | -$33 | $4,201 | $1,150 |
| Stock Issued | $7,860 | $53 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$101,546 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$100 | $94 | $0 | $0 |
| Financing Cash Flow | $7,728 | $114 | -$97,345 | $1,150 |
| Forex Effect | $55 | -$1 | $0 | $0 |
| Net Chg. in Cash | $3,045 | $57 | $9 | -$688 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $87 | $30 | $5 | $694 |
| End Cash | $3,132 | $87 | $14 | $5 |
| Free Cash Flow | -$4,748 | -$56 | -$3,023 | -$688 |